Valeo Pharma Inc. provided earnings guidance for the year 2023. The company expects revenues to continue to grow this year with a target revenue base of $60-plus million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 CAD | +5.26% | +11.11% | -44.44% |
Apr. 25 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
Mar. 22 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.44% | 7.24M | |
+42.60% | 748B | |
+33.49% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.96% | 245B | |
+8.91% | 211B | |
-4.09% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- VPH Stock
- News Valeo Pharma Inc.
- Valeo Pharma Inc. Provides Earnings Guidance for the Year 2023